BioSpace News Archive

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that David Zaccardelli, Pharm.

Addex Therapeutics, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced that it will issue its Q3 2021 financial results on Thursday, November 4, 2021.

The measles, mumps, and rubella vaccines market is observing significant growth due to high incidence of pneumococcal infections.

One the key feature of the competitive landscape of the global hyperbaric oxygen therapy devices market is its diversity.

Transparency Market Research has published a new report titled, ‘Dental Practice Management Software Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027’.

Covis Pharma Group, a global specialty pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses, announced that Covis Pharma GmbH has acquired Eklira®, known as Tudorza® in the US and marketed as Bretaris® in some countries, and Duaklir®, marketed as Brimica® in some countries, from AstraZeneca.

Canadian pharmacogenetic testing provider, Inagene Diagnostics Inc., has partnered with fellow Canadian health-tech company, Granville Biomedical Inc., to add Canadian researched and developed medical grade swabs to its testing kits, bringing the best of locally manufactured medical products to Canadians.

Exact Sciences Corp. announced that company management will participate in the following conferences and invited investors to participate by webcast.

Bionomics Limited, a clinical-stage biopharmaceutical company, is pleased to announce that it has received U.S. Food and Drug Administration clearance to proceed with evaluating its lead clinical compound, BNC210, for the acute treatment of Social Anxiety Disorder in a Phase 2 clinical trial named the PREVAIL Study.

Vensica Therapeutics, a clinical stage biopharmaceutical company, announced that it has closed an investment round of $16 million.